VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MGX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MGXMetagenomi, Inc. Common Stock
$1.20$45M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMGXQuarterly Financials

Metagenomi, Inc. Common Stock (MGX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Metagenomi, Inc. Common Stock (MGX) quarterly income statement — complete revenue, gross profit & net income history

MGX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q1'22
Sales/Revenue1.25M3.91M8.66M8.51M4.13M9.61M11.51M20.01M11.16M12.4M12.36M11.34M8.66M5.59M3.35M
Revenue Growth %-69.76%-59.32%-24.8%-57.45%-63.02%-22.46%-6.87%76.48%28.9%121.61%--158.73%--
Cost of Goods Sold01.3M1.32M22.51M000031.44M24.75M26.84M22.68M20.13M719K8.43M
COGS % of Revenue-33.24%15.29%264.38%----281.74%199.65%217.08%200.06%232.53%12.85%251.87%
Gross Profit1.25M2.61M7.33M-13.99M4.13M9.61M11.51M20.01M-20.28M-12.36M-14.47M-11.34M-11.47M4.88M-5.08M
Gross Margin %100%66.76%84.71%-164.38%100%100%100%100%-181.74%-99.65%-117.08%-100.06%-132.53%87.15%-151.87%
Gross Profit Growth %-69.76%-72.84%-36.29%-169.94%120.35%177.81%179.55%276.38%-76.76%-353.4%---125.78%--
Operating Expenses25.84M26.98M30.17M6.99M31.95M30.24M33.9M36.87M8.75M7.84M7.92M6.62M6.46M20.64M3.92M
OpEx % of Revenue2070.11%689.8%348.47%82.14%774.1%314.51%294.4%184.28%78.43%63.23%64.07%58.38%74.68%368.94%117.07%
Selling, General & Admin6.54M5.48M6.21M6.99M6.8M7.07M7.64M8.55M8.75M7.84M7.92M6.62M6.46M5.58M3.92M
SG&A % of Revenue523.64%140.04%71.78%82.14%164.89%73.57%66.36%42.74%78.43%63.23%64.07%58.38%74.68%99.82%117.07%
Research & Development19.3M21.5M23.96M22.51M25.14M23.16M26.26M28.32M31.44M24.75M26.84M22.68M20.13M15.06M8.43M
R&D % of Revenue1546.47%549.76%276.69%264.38%609.21%240.94%228.04%141.54%281.74%199.65%217.08%200.06%232.53%269.12%251.87%
Other Operating Expenses000-1000K0000-1000K-1000K-1000K-1000K-1000K0-1000K
Operating Income-24.59M-24.37M-22.84M-20.99M-27.82M-20.62M-22.38M-16.86M-29.03M-20.2M-22.39M-17.96M-17.94M-15.77M-9M
Operating Margin %-1970.11%-623.04%-263.76%-246.53%-674.1%-214.51%-194.4%-84.28%-260.17%-162.88%-181.15%-158.45%-207.21%-281.79%-268.93%
Operating Income Growth %11.62%-18.15%-2.04%-24.46%4.17%-2.11%0.05%6.12%-61.85%-28.1%---99.34%--
EBITDA-23.05M-23.07M-21.52M-19.65M-26.46M-19.16M-21.02M-15.55M-27.76M-19M-21.24M-16.95M-17.1M-15.05M-8.74M
EBITDA Margin %-1846.88%-589.8%-248.47%-230.85%-641.19%-199.31%-182.55%-77.74%-248.76%-153.2%-171.81%-149.53%-197.49%-268.94%-261.13%
EBITDA Growth %12.9%-20.38%-2.36%-26.35%4.67%-0.88%1.05%8.25%-62.36%-26.24%---95.67%--
D&A (Non-Cash Add-back)01.3M1.32M1.33M1.36M1.46M1.36M1.31M1.27M1.2M1.15M1.01M841K719K261K
EBIT-23.05M-24.37M-20.63M-20.99M-27.82M-20.62M-22.38M-16.86M-29.03M-20.2M-22.39M-17.96M-17.94M-13.78M-9M
Net Interest Income1.54M1.88M2.21M2.48M2.89M3.2M3.62M3.98M3.93M3.63M3.87M3.97M4M1.93M156.5K
Interest Income1.54M1.88M2.21M2.48M2.89M3.2M3.62M3.98M3.93M3.63M3.87M3.97M4M1.93M156.5K
Interest Expense000000000000000
Other Income/Expense1.54M1.87M2.21M1.12M2.88M-3.98M1.5M3.92M3.88M3.63M3.78M6.85M4M1.99M252K
Pretax Income-23.05M-22.49M-20.63M-19.86M-24.94M-24.61M-20.88M-12.94M-25.15M-16.57M-18.61M-11.11M-13.94M-13.78M-8.75M
Pretax Margin %-1846.88%-575.15%-238.21%-233.34%-604.34%-255.94%-181.34%-64.66%-225.36%-133.62%-150.56%-98%-160.98%-246.31%-261.4%
Income Tax-10K34K-234K44K98K-1.21M-2.11M-2.2M02.73M1.21M1.9M2.2M846K546K
Effective Tax Rate %0.04%-0.15%1.13%-0.22%-0.39%4.91%10.09%17%0%-16.45%-6.48%-17.08%-15.76%-6.14%-6.24%
Net Income-23.06M-22.53M-20.39M-19.91M-25.04M-23.4M-18.77M-10.74M-25.15M-19.29M-19.82M-13.01M-16.13M-14.63M-9.29M
Net Margin %-1847.68%-576.02%-235.51%-233.85%-606.71%-243.37%-163.04%-53.67%-225.36%-155.61%-160.32%-114.74%-186.36%-261.43%-277.72%
Net Income Growth %7.91%3.72%-8.63%-85.38%0.43%-21.27%5.28%17.44%-55.88%-31.91%---73.61%--
Net Income (Continuing)-23.04M-22.53M-20.39M-19.91M-25.04M-23.4M-18.77M-10.74M-25.15M-19.29M-19.82M-13.01M-16.13M-14.63M-9.29M
Discontinued Operations000000000000000
Minority Interest000000000000000
EPS (Diluted)-0.61-0.60-0.55-0.54-0.68-0.63-0.51-0.29-0.67-0.51-0.53-0.35-0.54-0.39-1.57
EPS Growth %10.29%4.76%-7.84%-86.21%-1.49%-23.53%3.77%16.47%-24.07%-30.67%--65.61%--
EPS (Basic)-0.61-0.60-0.55-0.54-0.68-0.63-0.51-0.29-0.67-0.51-0.53-0.35-0.54-0.39-1.57
Diluted Shares Outstanding37.58M37.62M37.35M37.16M37.02M37.09M36.77M37.46M37.47M37.47M37.47M37.47M29.96M37.47M5.93M
Basic Shares Outstanding37.58M37.62M37.35M37.16M37.02M37.09M36.77M37.46M37.47M37.47M37.47M37.47M29.96M37.47M5.93M
Dividend Payout Ratio---------------